Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04603287
What this trial is testing

SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT03641547
What this trial is testing

M6620 Plus Standard Treatment in Oesophageal and Other Cancer

Who this might be right for
Oesophageal AdenocarcinomaSquamous Cell CarcinomaSolid Tumor
University of Oxford 36
Testing effectiveness (Phase 2)UnknownNCT04481100
What this trial is testing

CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer

Who this might be right for
Esophageal NeoplasmEsophageal DiseasesEsophageal Squamous Cell Carcinoma
Hangzhou Cancer Hospital 38
Not applicableUnknownNCT05561699
What this trial is testing

Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 66
Not applicableUnknownNCT02908204
What this trial is testing

Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasms
Shanghai Zhongshan Hospital 1,800
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06303583
What this trial is testing

Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Qiu Guoqin 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06165380
What this trial is testing

Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapies
Li Zhang 43
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Testing effectiveness (Phase 2)Study completedNCT00268346
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01469598
What this trial is testing

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

Who this might be right for
Metastatic CarcinomaRecurrent Esophageal Squamous Cell Carcinoma
Samsung Medical Center 24
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Early research (Phase 1)Study completedNCT03708328
What this trial is testing

A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid TumorsMetastatic MelanomaNon-small Cell Lung Cancer (NSCLC)+2 more
Hoffmann-La Roche 134
Large-scale testing (Phase 3)Active Not RecruitingNCT05043688
What this trial is testing

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li 426
Testing effectiveness (Phase 2)Study completedNCT02446574
What this trial is testing

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasms
Chinese Academy of Medical Sciences 33
Testing effectiveness (Phase 2)UnknownNCT01232374
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd. 144
Testing effectiveness (Phase 2)Looking for participantsNCT06489197
What this trial is testing

AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

Who this might be right for
ESCCAdvanced Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06908382
What this trial is testing

Neoadjuvant QL1706 Therapy for ESCC

Who this might be right for
Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Shandong Provincial Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07039162
What this trial is testing

Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Locally Advanced Unresectable Esophageal Cancer
Ming-Yu Lien 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07244978
What this trial is testing

Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 49
Early research (Phase 1)Study completedNCT02964455
What this trial is testing

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 12
Next Page